Ticker: COYA

Coya Therapeutics, Inc. (NASDAQ: COYA) - quick read on the company's Q2 2025 situation and income-statement health. At a glance * Cash (6/30/2025): $29,757,328 * Total assets (6/30/2025): $33,452,555 * Total liabilities (6/30/2025): $5,142,262 * Stockholders' equity (6/30/2025): $28,310,293 * Acc...

Coya Therapeutics, Inc. (NASDAQ: COYA) reported its quarterly financial results for the period ending March 31, 2025. The company is focused on developing proprietary therapies targeting regulatory T cells to address various diseases. Key Highlights from the Income Statement: Collaboration reven...